# IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors

> **NCT04510792** · — · WITHDRAWN · sponsor: **Portsmouth Hospitals NHS Trust**

## Conditions studied

- Hyperkalemia

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT04510792
- **Lead sponsor:** Portsmouth Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-07-12
- **Primary completion:** 2021-07-12
- **Final completion:** 2021-07-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** withdrawn
- **Last updated:** 2025-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04510792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04510792, "IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04510792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*